+499.5%
MRNA vs ARES
-18.2%
+517.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ARES | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.0% | -1.3% | -1.8% |
| 7D | +5.5% | -1.7% | +7.1% | +6.1% |
| 30D | +158.7% | +0.3% | +158.5% | +160.4% |
| 3M | +182.1% | +8.5% | +173.7% | +178.0% |
| 6M | +151.8% | +23.5% | +128.3% | +140.3% |
| YTD | +393.6% | -11.2% | +404.8% | +393.6% |
| 1Y | +499.5% | -19.3% | +518.8% | +508.6% |
| All | +499.5% | -18.2% | +517.7% | +508.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ARES.
Daily Out/Under-Performance
Portfolio return minus ARES return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARES return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ARES wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling